Mestinon retard

Mestinon retard is a medicine authorised by Swissmedic under authorisation number 56387. The authorisation holder is MEDA Pharmaceuticals Switzerland GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 September 2010 and the authorisation is valid without a time limit. ATC code N07AA02 places the medicine in the group Other nervous system drugs.

  • Dispensing category B
  • Authorisation number 56387
  • ATC N07AA02
  • Synthetic medicines
Authorisation data
Authorisation number56387
NameMestinon retard
Full nameMestinon retard, Tabletten
Authorisation holderMEDA Pharmaceuticals Switzerland GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN07AA02
First authorisation01 September 2010
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Mestinon retard, TablettenB01 September 2010

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1100Tablette(n)N07AA0201.14.0.B
2100Tablette(n)N07AA0201.14.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Mestinon retard authorised in Switzerland?

Yes. Mestinon retard is authorised by Swissmedic under authorisation number 56387, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Mestinon retard have?

Mestinon retard is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Mestinon retard?

The authorisation holder is MEDA Pharmaceuticals Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com